Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Pediatr Hematol Oncol ; 41(1): 64-66, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-29683948

RESUMEN

Mutations in interleukin-10 and its receptors cause infantile inflammatory bowel disease (IBD), a hyperinflammatory disorder characterized by severe, treatment-refractory colitis, multiple abscesses, and enterocutaneous fistulas. Patients with infantile IBD often require several surgical interventions, including complete colectomy, and hematopoietic stem cell transplantation is currently the only known medical therapy. Traditionally, operative management has been preferred before stem cell transplantation because of the latter's increased susceptibility to procedural complications; however, surgical intervention could be delayed, and possibly reconsidered, because our 2 patients with infantile IBD demonstrated a rapid response to treatment via engraftment.


Asunto(s)
Aloinjertos , Trasplante de Células Madre Hematopoyéticas , Enfermedades Inflamatorias del Intestino/genética , Enfermedades Inflamatorias del Intestino/terapia , Receptores de Interleucina-10/deficiencia , Donante no Emparentado , Humanos , Lactante , Masculino
2.
Pediatr Transplant ; 17(7): E156-60, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23962034

RESUMEN

CD is defined as T-lymphocyte-mediated gluten sensitivity. Although CD is known to affect the small intestine, it is nonetheless a multisystem disorder. Liver involvement in CD may vary from isolated hypertransaminasemia to cirrhosis. Because CD is an inappropriate immune response to gluten proteins, strict gluten-free diet is the principal therapy, along with management of liver dysfunction. In patients who fail to respond to a gluten-free diet, immunosuppressive drugs may improve intestinal inflammatory activity in untreated CD. The present case report is of a 25-yr-old woman with diarrhea lasting several weeks. The patient had received a liver transplant 13 yr earlier, and presented with cryptogenic cirrhosis diagnosed as CD. This appears to be the first case of its kind in which a pediatric long-term liver transplant patient presents with diarrhea eventually diagnosed as CD whose diet included gluten, and who was treated by an immunosuppressive drug regimen. Because of the normalization of CD-related antibodies in the post-transplantation period without gluten restriction, CD should be part of a list of diagnostic possibilities in liver transplant patients presenting with diarrhea of unknown etiology.


Asunto(s)
Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/inmunología , Enfermedad Celíaca/diagnóstico , Enfermedad Celíaca/etiología , Inmunosupresores/uso terapéutico , Trasplante de Hígado/efectos adversos , Adulto , Enfermedad Celíaca/complicaciones , Diarrea/etiología , Dieta Sin Gluten , Endoscopía , Femenino , Humanos , Inflamación , Cirrosis Hepática/congénito , Cirrosis Hepática/etiología , Cirrosis Hepática/terapia , Hepatopatías/complicaciones , Hepatopatías/terapia , Factores de Tiempo
3.
Pediatr Transplant ; 13(3): 375-8, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-18452496

RESUMEN

SRL is a new and potent immunosuppressive agent that has been successfully introduced in organ transplantation. In contrast to other immunosuppressive agents, SRL has a potent antitumor activity both in vitro and in vivo. Herein, we report a child with Kaposi's sarcoma that was diagnosed 30 months after LDLT and treated successfully with only conversion to SRL monotherapy. KS regressed completely at the end of the first month and remained in remission during 28 months follow-up.


Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Trasplante de Hígado/efectos adversos , Sarcoma de Kaposi/tratamiento farmacológico , Sirolimus/uso terapéutico , Femenino , Humanos , Lactante , Donadores Vivos , Sarcoma de Kaposi/etiología , Sarcoma de Kaposi/inmunología , Tacrolimus/efectos adversos , Resultado del Tratamiento
4.
Pediatr Transplant ; 13(3): 300-6, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-18537904

RESUMEN

Prolonged QTc interval (>440 ms) is a common abnormality in adult patients with CLD and has been reported to predict patient survival. In this study, 88 children who underwent evaluation for LT, including a 12-lead electrocardiogram and echocardiogram included to determine the frequency of QTc prolongation and related factors in children with CLD and the effect of LT on these factors. Sixty-nine healthy, age- and sex-matched children served as controls. QTc interval was prolonged in 40 CLD patients (45.4%). It was found to be related to PELD score and presence of portal hypertension. Mean QTc was higher in patients who died prior to LT than in the survivors without LT. Mortality risk was increased 3.66-fold in patients with prolonged QTc (p = 0.001, 95% CI: 2-7.2). Cox regression analysis showed that only PELD score was an independent predictor of survival (p = 0.001, beta = -0.41, 95% CI: 5.58-1.82). Five of 48 transplanted children died within three months post-transplant; QTc was not related to post-transplant survival (p = 0.27). QTc normalized in 63.8% patients after LT. After LT, LAD, LVEF, and LVPWT decreased. In conclusion, QTc prolongation is common in children with CLD and associated with high mortality. It may be useful for assessment of the severity of CLD and for the timing for transplantation.


Asunto(s)
Arritmias Cardíacas/fisiopatología , Hepatopatías/fisiopatología , Hepatopatías/cirugía , Trasplante de Hígado , Adolescente , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/etiología , Arritmias Cardíacas/mortalidad , Niño , Preescolar , Enfermedad Crónica , Electrocardiografía , Femenino , Humanos , Lactante , Hepatopatías/complicaciones , Hepatopatías/mortalidad , Estudios Longitudinales , Masculino , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA